SDB-006

SDB-006_structure.png

SDB-006 is a synthetic cannabinoid that belongs to the indazole-3-carboxamide family. It is a designer drug that has been sold online as a "research chemical." SDB-006 is known for its potent agonistic activity at the cannabinoid receptors, specifically the CB1 and CB2 receptors.

Chemical Structure and Properties

SDB-006 has a chemical structure that includes an indazole core, which is a bicyclic structure composed of a benzene ring fused to a pyrazole ring. The full chemical name of SDB-006 is N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide. The molecular formula is C18H26N4O2, and it has a molecular weight of 330.43 g/mol.

Pharmacology

SDB-006 acts as a potent agonist at the CB1 and CB2 receptors, which are part of the endocannabinoid system. This system is involved in regulating various physiological processes, including pain sensation, mood, and appetite. The activation of these receptors by SDB-006 can lead to psychoactive effects similar to those produced by tetrahydrocannabinol (THC), the primary psychoactive component of cannabis.

Legal Status

The legal status of SDB-006 varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. In other regions, it may be legal to possess and distribute for research purposes.

Health Risks and Safety

The use of SDB-006 has been associated with various adverse effects, including tachycardia, hypertension, nausea, and anxiety. Due to its potency and the lack of clinical studies, the long-term health effects of SDB-006 are not well understood. Users are advised to exercise caution and be aware of the potential risks.

Related Compounds

SDB-006 is structurally related to other synthetic cannabinoids, such as AB-FUBINACA, ADB-PINACA, and 5F-ADB. These compounds share similar pharmacological profiles and are often found in products marketed as legal alternatives to cannabis.

See Also

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• Designer drug

External Links

‎